Goldman Sachs’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Goldman Sachs’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-270,851	Closed	-$2.76M	–	5988
2023 Q3	$2.76M	Buy	270,851 +256,880	+1,839%	+$1.96M	﹤0.01%	3506
2023 Q2	$65.7K	Buy	13,971 +1,502	+12%	+$6.9K	﹤0.01%	5428
2023 Q1	$57.6K	Sell	12,469 -14,772	-54%	-$65K	﹤0.01%	5531
2022 Q4	$98.9K	Buy	27,241 +1,459	+6%	+$6.47K	﹤0.01%	5482
2022 Q3	$122K	Sell	25,782 -162	-0.6%	-$814	﹤0.01%	5635
2022 Q2	$125K	Buy	+25,944	New	+$158K	﹤0.01%	5798
2022 Q1	–	Sell	-31,828	Closed	-$198K	–	7035
2021 Q4	$198K	Sell	31,828 -3,172	-9%	-$24.8K	﹤0.01%	5911
2021 Q3	$303K	Buy	+35,000	New	+$286K	﹤0.01%	5493

Goldman Sachs's THRN Position: Q4 2023 in Review

Goldman Sachs sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 270,851 shares — an estimated $2.76M sold.

Goldman Sachs first reported a position in THRN in Q3 2021 and held it in 8 quarters. The position peaked at $2.76M in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

Goldman Sachs reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Goldman Sachs sold 270,851 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $2.76M.
Goldman Sachs first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
Goldman Sachs's Thorne Healthtech, Inc. Common Stock position peaked at $2.76M in Q3 2023.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Goldman Sachs's 13F filing for Q4 2023, filed 13 Feb 2024.